Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

FGSN vs CRBG: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CRBG Wins Head-to-Head Institutional Verdict (5–0 across 6 Pillars · 9–1 Matrix Metrics)

CRBG Overall Winner 6-Pillar Tally: FGSN 0 – 5 CRBG (1 Tie) Matrix Metrics: FGSN 1 – 9 CRBG

As of Nov 17, 2026, Corebridge Financial, Inc. (CRBG) is the stronger overall head-to-head candidate over F&G Annuities & Life, Inc. 7.300% Junior Subordinated Notes due 2065 (FGSN) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). FGSN carries a Unified Composite Score of 28.2/100 (SELL) at $17.16 (N/M Forward P/E, N/A operating margin), whereas CRBG carries 52.9/100 (HOLD) at $35.01 (6.3x Forward P/E, 20.8% operating margin).

  • Technical & Structure Timing Caution: FGSN is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 30.0); meanwhile CRBG trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 47.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About FGSN vs CRBG
FGSN NYSE
F&G Annuities & Life, Inc. 7.300% Junior Subordinated Notes due 2065
Life Insurance
$17.16
-0.17% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.30β · 22% Vol
Unified Composite Score
28.2 / 100 SELL
Tech 14.0 Fund 41.0 Flow 50.0 Mom 59.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -5.0%), weak momentum, RSI 30
RSI-14: 30.0 · SMA20: $18.34 · SMA50: $19.21
CRBG NYSE Head-to-Head Winner
Corebridge Financial, Inc.
Life Insurance
$35.01
-1.97% 1D
Market Cap $15.9B
TTM Revenue $20.5B
Forward P/E 6.3x
Beta / 30D Vol 1.16β · 35% Vol
Unified Composite Score
52.9 / 100 HOLD
Tech 45.0 Fund 45.0 Flow 50.0 Mom 38.9
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 48
RSI-14: 47.9 · SMA20: $35.33 · SMA50: $34.75

6-Pillar Scorecard Institutional Category Breakdown (FGSN 0 – 5 CRBG)

Columns: Metric · FGSN · CRBG
1. Valuation Multiples CRBG
Forward P/E N/M 6.3x
Trailing P/E N/M 8.2x
PEG Ratio N/M N/M
EV / Revenue N/M 0.8x
2. Growth & Scale CRBG
Revenue Growth (YoY) N/A +18.6%
Earnings Growth (YoY) N/A N/A
TTM Revenue (USD) N/A $20.5B
Market Cap N/A $15.9B
3. Profitability & Quality CRBG
Gross Margin N/A 30.9%
Operating Margin N/A 20.8%
Net Profit Margin N/A 10.8%
Return on Equity (ROE) N/A 20.1%
4. Balance Sheet & Cash Flow CRBG
Cash Generation (TTM) N/A $4.97B EBITDA
Cash Flow Margin N/A 24.3% EBITDA Mgn
Net Cash / Leverage N/A ROE $14.16 Book/Sh · 20.1% ROE
Dividend Yield None (0.00%) 2.75%
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) 30.7% (5th %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Neutral
6. R&D & Supply-Chain Moat CRBG
OpEx & R&D Intensity N/A 10.1% of Rev ($2.07B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Scale & Operating Efficiency Moat
Supply-Chain Role Life Insurance Operator Asset Management Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: FGSN (1) vs CRBG (9)
Institutional Metric FGSN CRBG Criterion Row Edge
Market Capitalization
Scale
N/A $15.9B Larger Scale CRBG
Trailing P/E Ratio
Valuation
N/M 8.2x Lower Multiple CRBG
Forward P/E Ratio
Valuation
N/M 6.3x Lower Multiple CRBG
Revenue Growth (YoY)
Growth
N/A +18.6% Higher Growth CRBG
Operating Margin (TTM)
Profitability
N/A 20.8% Higher Margin CRBG
Net Profit Margin
Profitability
N/A 10.8% Higher Margin CRBG
Return on Equity (ROE)
Capital Efficiency
N/A 20.1% Higher ROE CRBG
52-Week Range Position
Momentum
4% ($17–$24) 88% ($22–$37) Stronger Trend CRBG
Beta / 30D Volatility
Risk Regime
0.30β · 22% Vol 1.16β · 35% Vol Lower Realized Risk FGSN
Unified Institutional Score
Composite Signal
28.2 / 100 (SELL) 52.9 / 100 (HOLD) Higher Composite CRBG
Trailing 12M Revenue (USD)
Operating Scale
N/A $20.5B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A 30.9% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · 0.8x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) $4.97B EBITDA ($14.16 Book/Sh · 20.1% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CRBG +11.37 pp
FGSN: -9.64% · CRBG: +1.73%
3M Horizon CRBG +25.36 pp
FGSN: -17.88% · CRBG: +7.48%
6M Horizon CRBG +52.42 pp
FGSN: -21.32% · CRBG: +31.1%
1Y Horizon CRBG +47.47 pp
FGSN: -27.26% · CRBG: +20.21%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on FGSN vs CRBG. Trailing 12-month operating profitability (FGSN N/A vs CRBG 20.8%) and valuation multiples (FGSN N/M vs CRBG 6.3x Forward P/E) are benchmarked directly in Pillar 4 below.

FGSN ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
CRBG ADR TTM Benchmark FX-Normalized USD
TTM Revenue$20.5B
Gross Margin30.9%
Op. Margin20.8%
ROE / Fwd P/E20.1% · 6.3x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
FGSN UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact FGSN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
CRBG UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 30.7%
IV Percentile 5th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact CRBG Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
FGSN Moat Profile Cyclical / Execution-Driven Positioning
Life Insurance Operator
Competes within the Life Insurance value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
CRBG Moat Profile Scale & Operating Efficiency Moat
Asset Management Operator
Competes within the Asset Management value chain with $15.9B market capitalization and 20.8% operating margin.
OpEx & R&D Reinvestment 10.1% of Rev ($2.07B)
90D Engineering Disclosures 0 Published

Investor FAQ FGSN vs CRBG Key Questions & Quantitative Answers

As of Nov 17, 2026, Corebridge Financial, Inc. (CRBG) is the stronger overall head-to-head candidate over F&G Annuities & Life, Inc. 7.300% Junior Subordinated Notes due 2065 (FGSN) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). FGSN carries a Unified Composite Score of 28.2/100 (SELL) at $17.16 (N/M Forward P/E, N/A operating margin), whereas CRBG carries 52.9/100 (HOLD) at $35.01 (6.3x Forward P/E, 20.8% operating margin). Technical & Structure Timing Caution: FGSN is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 30.0); meanwhile CRBG trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 47.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

CRBG leads the Growth & Scale pillar: FGSN posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with CRBG at +18.6% YoY revenue growth and N/A YoY earnings growth on $20.5B TTM revenue (30.9% gross margin, 20.8% operating margin). On trailing 12-month operating scale, FGSN generates N/A in USD-normalized revenue versus $20.5B for CRBG. In operating R&D and SG&A reinvestment, FGSN deploys N/A (0 90-day corporate R&D disclosures) versus 10.1% of Rev ($2.07B) (0 disclosures) for CRBG.

CRBG screens cheaper on headline valuation multiples. FGSN trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas CRBG trades at 6.3x Forward P/E, 8.2x Trailing P/E, N/M PEG, and 0.8x EV/Revenue (24.3% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against FGSN (N/A ROE) versus CRBG (20.1% ROE) capital efficiency.

In options market volatility and institutional positioning, FGSN carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.30β · 22% Vol realized risk). By comparison, CRBG carries 30.7% implied volatility (5th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.16β · 35% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.